Dr. Erin Dickerson, University of Minnesota – Investigating the role of hemangiosarcoma subtypes in influencing treatment efficacy for affected dogs.
Dr. Andrea Pires dos Santos, Purdue University – Pioneering research on the feasibility of using microRNAs as an early detection tool for hemangiosarcoma.
Dr. Jong Hyuk Kim, University of Florida – Exploring the impact of a genetic mutation that occurs in approximately one-third of dogs diagnosed with hemangiosarcoma, with the goal of developing innovative therapies.
Dr. Frances Chen, University of Massachusetts – Devising statistical breeding models to reduce the incidence of hemangiosarcoma within dog breeds.
Dr. Jiho Kim, Protein Advances Incorporated Life Sciences – Investigating the presence of specific proteins in hemangiosarcoma tumors, which may serve as potential therapy targets.
Dr. Alexandre Le Roux, Schwarzman Animal Medical Center – Pioneering a technique called single-cell RNA sequencing to identify unique surface markers in canine hemangiosarcoma cells, a crucial step toward the development of precise radiation therapy.
Keep an eye on Hemangio.com for further updates on these cutting-edge studies, all of which are pivotal in the fight against canine hemangiosarcoma. Together, we’re making strides in understanding and combating this deadly disease.
